Protagonist Therapeutics Stock News & Updates
[WKN: A2AP32 | Symbol: PTGX]
Protagonist Therapeutics
Protagonist Therapeutics: Peptide Therapies Drive Record Revenue with ICOTYDE Approval
TOP-5 Analyst Price Targets on 06.05.26
Life Time Group [US53190C1027] Jefferies reaffirms Buy rating and adjusts the price target from $40...
Protagonist Therapeutics - Biotech Company in the Crosshairs of Johnson & Johnson!
Business Driver: Protagonist Therapeutics (PTGS) specializes in the development of peptide-based therapeutics,...
The NEO-DARVAS STRATEGY: Protagonist Therapeutics, Porch Group, and Aris Water Solutions,
The NEO-DARVAS STRATEGY is a remarkable trend-following approach based on a simple yet powerful concept:...
Protagonist Therapeutics: Transforming Healthcare With top-Quality Peptide Drugs
Protagonist Therapeutics is a biopharmaceutical company in the clinical stage focused on the discovery...
- ‹
- 1
- ›